The bioinformatics analysis of immunotherapy-resistant lung adenocarcinoma patients and the system analysis of Anti-PD1-resistant mice models once again validate that the resistance-associated Wnt/β-catenin pathway offers a promising avenue for immune checkpoint inhibitors sensitization.
[Small]